PURPOSE To determine the expression of luteinizing hormone releasing hormone (LHRH) receptors in specimens and cell lines of human renal cell carcinoma (RCC) and to evaluate the antitumor efficacy of targeted therapy with a cytotoxic analogue of LHRH, AN-207, in vivo. AN-207, consisting of [D-Lys(6)] LHRH linked to a cytotoxic radical, 2-pyrrolinodoxorubicin (AN-201), binds with high affinity t...

Abstract Study question Is there an advantage for modified flare/ GnRH antagonist protocol in comparison to oocyte cryopreservation cycles? Summary answer Modified is at least as good cycles, potentially improving maturity rate subgroup of patients. What known already Ultrashort flare agonist (GnRHa)/GnRH -antagonist offer benefits stimulatory effect repeated microdose on endogenous FSH and the...

PURPOSE AND EXPERIMENTAL DESIGN To improve conventional chemotherapy, we developed cytotoxic analogues of luteinizing hormone-releasing hormone (LH-RH), which can be targeted to prostate cancers expressing LH-RH receptors. In view of pending clinical trials on cytotoxic LH-RH analogue AN-152, containing doxorubicin (DOX) linked to [D-Lys(6])-LH-RH, we investigated the effects of AN-152 on tumor...

Preovulatory rise in progesterone Dear Sir, We read with great interest the article by Eldar-Geva et al. (1998). In the late follicular phase of gonadotrophin-releasing hormone (GnRH) agonist/human menopausal gonadotrophin (HMG)-stimulated cycles they showed a concomitant increase of serum progesterone and luteinizing hormone (LH), both of which were reversible by the administration of dexameth...

longer half-life [ 24 h versus 60 min for LH (Yen et al., A new treatment option for patients undergoing ovarian 1968; Damewood et al., 1989)], HCG administration results stimulation is the gonadotrophin-releasing hormone in a prolonged luteotrophic effect, characterized by the develop(GnRH) antagonist protocol, with the possibility to trigger ment of multiple corpora lutea and supraphysiologic...

Objective: To detect the effect of late coasting on oocyte quality. Design: Retrospective study. Setting: Samir Abbas Medical Center Materials and methods: Patients where estradiol level was over 4000 pg/ml and late coasting was used as a method to prevent OHSS, and patients where estradiol level was over 4000 pg / ml but no coasting was done Main outcome measure(s) : Oocyte quality. Results: n...

The aim of this study is to compare clinical pregnancy rates in ICSI-ET cycles where GnRH agonist or hCG was used to induce final maturation of the oocytes. A total of 97 women who produced more than 14 follicles following ovulation induction with recombinant FSH and GnRH antagonist were selected for randomization. Human chorionic gonadotropin (hCG, 5.000 IU, IM) or GnRH agonist (triptorelin 0....